Solid Biosciences (SLDB) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free SLDB Stock Alerts $10.44 +0.10 (+0.97%) (As of 09:30 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - May 2 at 4:05 PMSolid Biosciences Inc. (NASDAQ:SLDB) Short Interest Up 49.8% in Marchmarketbeat.com - April 13 at 8:12 PMBuy Solid Biosciences: Unpacking Its Main Value Driverseekingalpha.com - April 10 at 9:37 PMSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 3 at 4:05 PMSolid Biosciences: FDA Grants Rare Pediatric Disease Designation For SGT-003markets.businessinsider.com - April 1 at 9:56 AMSolid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003globenewswire.com - April 1 at 7:45 AMWilliam Blair starts Solid Biosciences at outperformmsn.com - March 28 at 1:58 PMSolid Biosciences Inc. (NASDAQ:SLDB) Given Average Recommendation of "Buy" by Analystsmarketbeat.com - March 28 at 8:32 AMSolid Biosciences' (SLDB) Outperform Rating Reaffirmed at William Blairmarketbeat.com - March 28 at 8:29 AMSolid Biosciences (NASDAQ:SLDB) Reaches New 1-Year High at $14.99marketbeat.com - March 27 at 4:20 PMSolid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposiumfinance.yahoo.com - March 27 at 10:24 AMSLDB Apr 2024 7.500 putfinance.yahoo.com - March 24 at 7:35 PMCautious Optimism Amidst Clinical Progress and Regulatory Hurdles for Solid Biosciencesmarkets.businessinsider.com - March 19 at 7:14 AMBarclays Increases Solid Biosciences (NASDAQ:SLDB) Price Target to $21.00marketbeat.com - March 18 at 5:32 PMSolid Biosciences (NASDAQ:SLDB) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - March 18 at 4:34 PMSolid Biosciences (SLDB) Gets a Buy from Barclaysmarkets.businessinsider.com - March 18 at 9:36 AMSLDB Sep 2024 17.500 callfinance.yahoo.com - March 16 at 9:18 AMSolid Biosciences (NASDAQ:SLDB) Receives New Coverage from Analysts at Citigroupmarketbeat.com - March 15 at 8:17 AMBuy Rating Affirmed for Solid Biosciences on Promising Pipeline and Financial Stabilitymarkets.businessinsider.com - March 14 at 12:30 PMSolid Biosciences (NASDAQ:SLDB) Upgraded to Overweight at Piper Sandlermarketbeat.com - March 14 at 8:38 AMSolid Biosciences Inc.: Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Resultsfinanznachrichten.de - March 13 at 3:36 PMSolid Biosciences Stock Drops 4% Due To Wider Loss In Q4markets.businessinsider.com - March 13 at 3:36 PMSolid Biosciences, Cue Biopharma, Annexon among healthcare moversmsn.com - March 13 at 10:36 AMSolid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Resultsglobenewswire.com - March 13 at 7:44 AMSolid Biosciences price target raised by $7 at H.C. Wainwright, here's whyrealmoney.thestreet.com - March 11 at 12:25 PMLeerink Partners Keeps Their Hold Rating on Solid Biosciences (SLDB)markets.businessinsider.com - March 11 at 7:24 AMSolid Biosciences signs agreement with Armatus Bio for AAV-SLB101msn.com - March 7 at 10:59 AMSolid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHDfinance.yahoo.com - March 7 at 10:59 AMSolid Biosciences Inc. (NASDAQ:SLDB) Short Interest Updatemarketbeat.com - March 1 at 10:54 PMSolid Biosciences Stock (NASDAQ:SLDB) Insider Tradesbenzinga.com - February 22 at 5:24 AMSolid Biosciences Stock (NASDAQ:SLDB), Short Interest Reportbenzinga.com - February 22 at 5:24 AMInsider Buying: Taking a Controlling Stake in a Struggling Retailer?msn.com - February 18 at 12:33 PMSLDB Mar 2024 10.000 putfinance.yahoo.com - February 17 at 3:21 PMHold Rating on Solid Biosciences Amid Gene Therapy Developments and Regulatory Milestonesmarkets.businessinsider.com - February 6 at 12:01 AMSolid Biosciences LLC (SLDB)investing.com - January 23 at 5:27 PMSolid Biosciences Inc.: Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003finanznachrichten.de - January 16 at 1:53 PMSolid Biosciences Granted FDA ODD For SGT-003markets.businessinsider.com - January 16 at 1:53 PMSolid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003finance.yahoo.com - January 16 at 1:53 PMSolid Biosciences (SLDB) Rises 271% in 3 Months: Here's Whyfinance.yahoo.com - January 15 at 3:47 PMSolid Biosciences Inc. (NASDAQ:SLDB) Short Interest Up 21.8% in Decembermarketbeat.com - January 14 at 10:14 PMPerceptive Advisors Llc Acquires 3,410,713 Shares of Solid Biosciences Inc. (NASDAQ:SLDB) Stockmarketbeat.com - January 12 at 6:35 PMSolid Biosciences wins FDA orphan status for muscle disorder therapymsn.com - January 12 at 1:31 PMInsider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) CFO Sells 3,935 Shares of Stockmarketbeat.com - January 11 at 6:49 PMmarketbeat.com - January 8 at 9:52 AMSolid Biosciences raises $109M through private placementmsn.com - January 8 at 8:53 AMSolid Biosciences Announces $109 Million Private Placementfinance.yahoo.com - January 8 at 8:53 AMSolid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 4 at 8:19 AMSolid Biosciences Stock (NASDAQ:SLDB), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 21 at 1:14 AMSolid Biosciences (SLDB) Price Target Increased by 6.67% to 7.34msn.com - December 16 at 3:40 PMHC Wainwright & Co. Initiates Coverage of Solid Biosciences (SLDB) with Buy Recommendationnasdaq.com - December 9 at 10:32 AM Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner. Click here to discover the AI chip company SLDB Media Mentions By Week SLDB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLDB News Sentiment▼-1.000.45▲Average Medical News Sentiment SLDB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLDB Articles This Week▼11▲SLDB Articles Average Week Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SOPHiA GENETICS News Today Ocugen News Today Caribou Biosciences News Today Tenaya Therapeutics News Today MeiraGTx News Today Jasper Therapeutics News Today Aura Biosciences News Today TScan Therapeutics News Today Anavex Life Sciences News Today Adaptimmune Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLDB) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
